Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novo Nordisk announced it cannot meet demand in the U.S. for its recently approved weight-loss drug semaglutide for at least the first half of 2022.A contractor filling syringes for Wegovy pens cannot comply with Good Manufacturing Practices and has halted manufacturing and deliveries, according to a company press release. Novo Nordisk says it expects to meet U.S. demand later in 2022 and
SMILE proved effective in correcting residual myopia and myopic astigmatism in pseudophakic eyes, leading to significant visual acuity gain.In a poster presented at the American Academy of Ophthalmology meeting, Anita Syla Lokaj, MD, PhD, and co-authors showed the results of a retrospective study of patients from Kosovo and other countries.
Researchers found increased incidence of Clostridioides difficile infection among patients with esophageal atresia with or without tracheoesophageal fistula undergoing proton pump inhibitor therapy, according to a poster. “Esophageal atresia/tracheoesophageal fistula (EA/TEF) patients are at an increased risk for GERD and its associated complications. Current ESPGHAN-NASPGHAN consensus
Rapid implementation of a cystic fibrosis care model including telemedicine was successful for monitoring lung function and identifying exacerbations during the COVID-19 pandemic, according to data published in Chest.The care model also enabled monitoring of BMI and decreased use of antibiotics.
The CDC’s Advisory Committee on Immunization Practices recently issued a universal recommendation that all adults aged 19 to 59 years receive the hepatitis B vaccine. “This new recommendation by the ACIP will be instrumental in raising adult hepatitis B vaccination rates in the U.S. to levels that will allow us to finally eliminate hepatitis B in this country,” Rita Kuwahara,